1. Kilic, T., R. Weissleder, and H. Lee, Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges. iScience, 2020. 23(8): p. 101406.
2. Barrangou, R. and L.A. Marraffini, CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Mol Cell, 2014. 54(2): p. 234-44.
3. Hsu, P.D., E.S. Lander, and F. Zhang, Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014. 157: p. 1262-1278.
4. Abudayyeh, O.O., et al., C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016. 353(6299): p. aaf5573.
5. Ackerman, C.M., et al., Massively multiplexed nucleic acid detection with Cas13. Nature, 2020. 582(7811): p. 277-282.
6. Barnes, K.G., et al., Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. Nature Communications, 2020. 11(1): p. 4131.
7. Gootenberg, J.S., et al., Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 2017.
8. Freije, C.A., et al., Programmable Inhibition and Detection of RNA Viruses Using Cas13. Mol Cell, 2019. 76(5): p. 826-837 e11.
9. Gootenberg, J.S., et al., Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science, 2018. 360(6387): p. 439-444.
10. Abudayyeh, O.O. and J.S. Gootenberg, CRISPR diagnostics. Science, 2021. 372(6545): p. 914-915.
11. Chertow, D.S., Next-generation diagnostics with CRISPR. Science, 2018. 360(6387): p. 381-382.
12. Zuo, X., C. Fan, and H.-Y. Chen, Biosensing: CRISPR-powered diagnostics. Nature Biomedical Engineering, 2017. 1(6): p. 0091.
13. Freije, C.A. and P.C. Sabeti, Detect and destroy: CRISPR-based technologies for the response against viruses. Cell Host Microbe, 2021. 29(5): p. 689-703.
14. McDermott, J.H., et al., The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting. Eur J Hum Genet, 2021.
15. van Dongen, J.E., et al., Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities. Biosens Bioelectron, 2020. 166: p. 112445.
16. Marsic, T., et al., Vigilant: An Engineered VirD2-Cas9 Complex for Lateral Flow Assay-Based Detection of SARS-CoV2. Nano Lett, 2021.
17. Broughton, J.P., et al., CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol, 2020. 38(7): p. 870-874.
18. Agrawal, S., et al., Rapid detection of SARS-CoV-2 with Cas13. medRxiv, 2020.
19. Patchsung, M., et al., Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nat Biomed Eng, 2020. 4(12): p. 1140-1149.
20. Arizti-Sanz, J., et al., Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. Nat Commun, 2020. 11(1): p. 5921.
21. Thompson, D. and Y. Lei, Mini review: Recent progress in RT-LAMP enabled COVID-19 detection. Sensors and Actuators Reports, 2020. 2(1): p. 100017.
22. Joung, J., et al., Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing. N Engl J Med, 2020. 383(15): p. 1492-1494.
23. Mabey, D., et al., Diagnostics for the developing world. Nat Rev Microbiol, 2004. 2(3): p. 231-40.
24. Koeck, D.E., et al., Herbinix hemicellulosilytica gen. nov., sp. nov., a thermophilic cellulose-degrading bacterium isolated from a thermophilic biogas reactor. Int J Syst Evol Microbiol, 2015. 65(8): p. 2365-2371.
25. East-Seletsky, A., et al., RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes. Mol Cell, 2017. 66(3): p. 373-383 e3.
26. Curtis, K.A., et al., A multiplexed RT-LAMP assay for detection of group M HIV-1 in plasma or whole blood. J Virol Methods, 2018. 255: p. 91-97.
27. Knott, G.J. and J.A. Doudna, CRISPR-Cas guides the future of genetic engineering. Science, 2018. 361(6405): p. 866-869.
28. Mahas, A., C. Neal Stewart, Jr., and M.M. Mahfouz, Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation. Biotechnol Adv, 2017.
29. Abbott, T.R., et al., Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell, 2020. 181(4): p. 865-876 e12.
30. Lotfi, M. and N. Rezaei, CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother, 2020. 131: p. 110738.
31. Gao, J., et al., A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy. Mol Ther Oncolytics, 2020. 19: p. 79-92.
32. Palaz, F., et al., CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research. ACS Synth Biol, 2021.
33. Kontermann, R.E., Strategies for extended serum half-life of protein therapeutics. Curr Opin Biotechnol, 2011. 22(6): p. 868-76.
34. Abudayyeh, O.O., et al., RNA targeting with CRISPR-Cas13. Nature, 2017. 550(7675): p. 280-284.
35. Harrington, L.B., et al., A thermostable Cas9 with increased lifetime in human plasma. Nat Commun, 2017. 8(1): p. 1424.
36. Narasimhan, D., et al., Structural analysis of thermostabilizing mutations of cocaine esterase. Protein Eng Des Sel, 2010. 23(7): p. 537-47.
37. Mougiakos, I., et al., Characterizing a thermostable Cas9 for bacterial genome editing and silencing. Nat Commun, 2017. 8(1): p. 1647.
38. Ali, Z., et al., iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2. Virus Res, 2020. 288: p. 198129.
39. Li, L., et al., HOLMESv2: A CRISPR-Cas12b-Assisted Platform for Nucleic Acid Detection and DNA Methylation Quantitation. ACS Synth Biol, 2019. 8(10): p. 2228-2237.
40. Santiago-Frangos, A., et al., Intrinsic Signal Amplification by Type-III CRISPR-Cas Systems Provides a Sequence-Specific Viral Diagnostic. medRxiv, 2020: p. 2020.10.14.20212670.
41. Steens, J.A., et al., SCOPE: Flexible targeting and stringent CARF activation enables type III CRISPR-Cas diagnostics. bioRxiv, 2021: p. 2021.02.01.429135.
42. Couvin, D., et al., CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins. Nucleic Acids Res, 2018. 46(W1): p. W246-W251.
43. Biswas, A., et al., CRISPRDetect: A flexible algorithm to define CRISPR arrays. BMC Genomics, 2016. 17: p. 356.
44. Kellner, M.J., et al., SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc, 2019. 14(10): p. 2986-3012.